SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CIANCETTA, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.219
EU - Europa 284
AS - Asia 265
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 1.771
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.217
SG - Singapore 104
IT - Italia 94
CN - Cina 81
TR - Turchia 52
PL - Polonia 38
UA - Ucraina 38
GB - Regno Unito 36
DE - Germania 28
SE - Svezia 21
ID - Indonesia 19
FI - Finlandia 12
CZ - Repubblica Ceca 8
BE - Belgio 5
HK - Hong Kong 4
CA - Canada 2
KR - Corea 2
RU - Federazione Russa 2
AT - Austria 1
CL - Cile 1
EU - Europa 1
FR - Francia 1
IR - Iran 1
NZ - Nuova Zelanda 1
TW - Taiwan 1
VN - Vietnam 1
Totale 1.771
Salva come PNG Salva come JPEG
Città #
Chandler 138
Fairfield 138
Ashburn 118
Ann Arbor 93
Houston 91
Woodbridge 85
Singapore 76
Ferrara 55
Jacksonville 54
Wilmington 50
Seattle 49
Princeton 46
Cambridge 44
Warsaw 38
Izmir 25
Shanghai 24
Jakarta 19
San Diego 18
Santa Clara 15
Beijing 12
Washington 12
London 11
Nanjing 11
Boardman 9
Falls Church 9
Brno 8
Los Angeles 7
Brussels 5
Changsha 5
Chicago 5
Milan 5
Redmond 5
Ferrara di Monte Baldo 4
Hong Kong 4
New York 4
Norwalk 4
Addison 3
Bologna 3
Chiswick 3
Helsinki 3
Jiaxing 3
Jinan 3
Zhengzhou 3
Bremen 2
Hebei 2
Kilburn 2
Kunming 2
Nanchang 2
Novara 2
Tianjin 2
Venice 2
Yeongdeungpo-gu 2
Brentford 1
Camerino 1
Changchun 1
Dearborn 1
Dong Ket 1
Dunedin 1
Forest City 1
Frankfurt am Main 1
Guangzhou 1
Hangzhou 1
Hounslow 1
Indiana 1
Islington 1
Kashan 1
Lanzhou 1
Mestre 1
Mountain View 1
Novokuznetsk 1
Padova 1
Palo del Colle 1
San Lazzaro di Savena 1
Saskatoon 1
Shenyang 1
Southfield 1
Southwark 1
Taipei 1
Tappahannock 1
Toronto 1
Wandsworth 1
Totale 1.364
Salva come PNG Salva come JPEG
Nome #
5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors 154
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 148
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists 126
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 124
The influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl moiety on the adenosine receptors affinity profile of pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c] pyrimidine derivatives 122
null 118
null 90
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 85
7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: Structural investigations at the 5-position to target human A(1) and A(2A) adenosine receptors. Molecular modeling and pharmacological studies 74
Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists 53
A 2a adenosine receptor: Structures, modeling, and medicinal chemistry 49
Bridging molecular docking to membrane molecular dynamics to investigate GPCR-ligand recognition: The human A2A adenosine receptor as a key study 35
A3 adenosine receptor activation mechanisms: molecular dynamics analysis of inactive, active, and fully active states 33
Enhancing Ligand and Protein Sampling Using Sequential Monte Carlo 33
Demystifying P2Y1 Receptor Ligand Recognition through Docking and Molecular Dynamics Analyses 29
Novel Aryl Sulfonamide Derivatives as NLRP3 Inflammasome Inhibitors for the Potential Treatment of Cancer 28
Deciphering the Complexity of Ligand-Protein Recognition Pathways Using Supervised Molecular Dynamics (SuMD) Simulations 28
A QM/MM study of the binding of RAPTA ligands to cathepsin B 28
DockBench: An Integrated Informatic Platform Bridging the Gap between the Robust Validation of Docking Protocols and Virtual Screening Simulations 27
Aquaporin inhibition by gold(III) compounds: New insights 26
Advances in Computational Techniques to Study GPCR-Ligand Recognition 24
Probe Confined Dynamic Mapping for G Protein-Coupled Receptor Allosteric Site Prediction 24
Design and in Vivo Characterization of A 1 Adenosine Receptor Agonists in the Native Ribose and Conformationally Constrained (N)-Methanocarba Series 24
Activation of carboplatin by chloride ions: a theoretical investigation 23
Conjugates between minor groove binders and Zn(II)-tach complexes: Synthesis, characterization, and interaction with plasmid DNA 23
Activation of Carboplatin by Carbonate 22
Sensitivity of Binding Free Energy Calculations to Initial Protein Crystal Structure 19
New Trends in Inspecting GPCR-ligand Recognition Process: the Contribution of the Molecular Modeling Section (MMS) at the University of Padova 19
Alternative quality assessment strategy to compare performances of GPCR-ligand docking protocols: the human adenosine A(2A) receptor as a case study 19
“Bitopic Fluorescent Antagonists of the A2A Adenosine Receptor Based on Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine Functionalized Congeners” 18
“Exploring the Recognition Pathway at the Human A2A Adenosine Receptor of the Endogenous Agonist Adenosine using Supervised Molecular Dynamics Simulations” 18
Understanding allosteric interactions in G protein-coupled receptors using Supervised Molecular Dynamics: A prototype study analysing the human A3 adenosine receptor positive allosteric modulator LUF6000 18
Rationalization of the inhibition activity of structurally related organometallic compounds against the drug target cathepsin B by DFT 17
Structure-Based Design of 3-(4-Aryl-1H-1,2,3-Triazol-1-yl)-Biphenyl Derivatives as P2Y14 Receptor Antagonists 16
Structure activity relationship of 2-arylalkynyl-adenine derivatives as human A3 adenosine receptor antagonists 16
Structure-Based Scaffold Repurposing for G Protein-Coupled Receptors: Transformation of Adenosine Derivatives into 5HT2B/5HT2C Serotonin Receptor Antagonists 15
Repurposing of a nucleoside scaffold from adenosine receptor agonists to opioid receptor antagonists 15
Pyrimidine nucleotides containing a (S)-methanocarba ring as P2Y6 receptor agonists 15
Structure-Guided Modification of Heterocyclic Antagonists of the P2Y 14 Receptor 14
Targeting Aquaporin Function: Potent Inhibition of Aquaglyceroporin-3 by a Gold-Based Compound 11
South (S)- and north (N)-methanocarba-7-deazaadenosine analogues as inhibitors of human adenosine kinase 10
Synthesis and Spectroscopic Characterisation of a Heterodinuclear Iron(III)-Copper(II) Complex Based on an Asymmetric Dinucleating Ligand System 10
HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS 10
Perturbation of fluid dynamics properties of water molecules during G protein-coupled receptor-ligand recognition: the human A2A adenosine receptor as a key study 9
Structural probing and molecular modeling of the A3 adenosine receptor: A focus on agonist binding 9
Influence of key amino acid mutation on the active site structure and on folding in acetyl-CoA synthase: A theoretical perspective 9
Implementing the “Best Template Searching” tool into Adenosiland platform 8
Polypharmacology of conformationally locked methanocarba nucleosides 8
Purine (N)-Methanocarba Nucleoside Derivatives Lacking an Exocyclic Amine as Selective A3 Adenosine Receptor Agonists 7
Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: Meeting new challenges 5
Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design 5
In silico 3D modeling of binding activities 5
Near-Complete Response to Osimertinib for Advanced Non-Small-Cell Lung Cancer in a Pretreated Patient Bearing Rare Compound Exon 20 Mutation (S768I + V774M): A Case Report 5
Enhancing torsional sampling using fully adaptive simulated tempering 3
“Protein-ligand docking: virtual screening and applications to drug discovery” 2
Totale 1.885
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.765
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 733
Totale 19.498
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020170 0 0 0 36 14 27 20 19 19 17 9 9
2020/2021221 13 7 15 20 7 24 7 25 16 45 32 10
2021/2022366 2 16 6 100 16 5 18 61 20 7 13 102
2022/2023313 51 22 24 21 40 26 8 44 47 9 13 8
2023/2024271 16 25 27 12 28 48 14 24 7 4 4 62
2024/2025138 19 21 98 0 0 0 0 0 0 0 0 0
Totale 1.885